Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange

Davies, Simon J. ; Lopez, Elvia Garcia ; Woodrow, Graham ; Donovan, Kieron ; Plum, Jorg ; Williams, Paul ; Johansson, Ann Catherine ; Bosselmann, Hans-Peter ; Heimburger, Olof and Simonsen, Ole LU , et al. (2008) Meeting of the International-Society-of-Peritoneal-Dialysis (EuroPD) 23(9). p.2982-2988
Abstract
Background. Randomized trials have shown that icodextrin reduces the volume of extra-cellular fluid (ECFv) with variable effects on residual renal function. To explore this fluid shift and its possible mechanisms in more detail, prospectively collected data from one such trial, including measures of inflammation (C-reactive protein, tumor necrosis factor-a, albumin and low and high molecular weight hyaluronan) ANP (atrial naturetic peptide), an indirect marker of intra-vascular Volume, plasma concentrations of icodextrin metabolites and alpha-amylase activity were analysed. Methods. 50 patients were randomized to either 2,27% glucose or icodextrin (n = 28) ford long exchange following a month run in. Blood samples were obtained at - 1, 0,... (More)
Background. Randomized trials have shown that icodextrin reduces the volume of extra-cellular fluid (ECFv) with variable effects on residual renal function. To explore this fluid shift and its possible mechanisms in more detail, prospectively collected data from one such trial, including measures of inflammation (C-reactive protein, tumor necrosis factor-a, albumin and low and high molecular weight hyaluronan) ANP (atrial naturetic peptide), an indirect marker of intra-vascular Volume, plasma concentrations of icodextrin metabolites and alpha-amylase activity were analysed. Methods. 50 patients were randomized to either 2,27% glucose or icodextrin (n = 28) ford long exchange following a month run in. Blood samples were obtained at - 1, 0, 3 and 6 months, coincident with measurements Of urine volume and fluid status. Results. In both randomized groups, a significant correlation between the fall in ECFv and the decline in urine Volume was observed (P = 0.001), although the relative drop in urine volume for patients randomized to icodextrin tended to be less. At baseline, ANP was higher in patients with proportionately more ECFv for a given body water or height. Icodextrin patients had non-significantly higher ANP levels at baseline, whereas by 3 (P = 0.026) and 6 months (P = 0.016) these differed between groups due to divergence. There was a correlation between increasing ANP and reduced ECF at 3 months, r = -0.46, P = 0.007. in patients randomized to icodextrin, but not glucose. There were no relationships between fluid Status and any inflammatory markers at any point of the Study, with the exception of albumin at baseline, r = -0.39, P = 0.007. Amylase activities at -1 month and baseline were highly correlated, r = 0.89, P < 0.0001. Within patients, concentrations of icodextrin metabolites were highly correlated: the only predictor of between-patient variability oil multivariate analysis was body weight. There was no relationship between plasma concentrations of icodextrin metabolites and any of the other clinical parameters, including change in daily Ultrafiltration, urine volume, fluid or inflammatory status. Conclusions. This analysis supports observational data that changes in fluid status are associated with changes ill urine volume. Icodextrin was not associated with a greater fall ill urine Output despite its larger effect on ECFv Changes ill fluid status Could not be explained or did not appeal to influence systemic inflammation. Nor call they be explained by individual variability in plasma concentrations of icodextrin that are in turn inversely proportional to the volume of distribution. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Chapter in Book/Report/Conference proceeding
publication status
published
subject
keywords
icodextrin, inflammation, fluid status, amylase, bioimpedance
host publication
NEPHROLOGY DIALYSIS TRANSPLANTATION
volume
23
issue
9
pages
2982 - 2988
publisher
Oxford University Press
conference name
Meeting of the International-Society-of-Peritoneal-Dialysis (EuroPD)
conference dates
2005-10-15 - 2005-10-18
external identifiers
  • wos:000259372400043
  • scopus:58549112395
  • pmid:18456678
ISSN
0931-0509
DOI
10.1093/ndt/gfn176
language
English
LU publication?
yes
id
56895367-7a88-4821-abe5-288418721c4c (old id 1287232)
date added to LUP
2016-04-01 13:27:36
date last changed
2022-01-27 19:19:43
@inproceedings{56895367-7a88-4821-abe5-288418721c4c,
  abstract     = {{Background. Randomized trials have shown that icodextrin reduces the volume of extra-cellular fluid (ECFv) with variable effects on residual renal function. To explore this fluid shift and its possible mechanisms in more detail, prospectively collected data from one such trial, including measures of inflammation (C-reactive protein, tumor necrosis factor-a, albumin and low and high molecular weight hyaluronan) ANP (atrial naturetic peptide), an indirect marker of intra-vascular Volume, plasma concentrations of icodextrin metabolites and alpha-amylase activity were analysed. Methods. 50 patients were randomized to either 2,27% glucose or icodextrin (n = 28) ford long exchange following a month run in. Blood samples were obtained at - 1, 0, 3 and 6 months, coincident with measurements Of urine volume and fluid status. Results. In both randomized groups, a significant correlation between the fall in ECFv and the decline in urine Volume was observed (P = 0.001), although the relative drop in urine volume for patients randomized to icodextrin tended to be less. At baseline, ANP was higher in patients with proportionately more ECFv for a given body water or height. Icodextrin patients had non-significantly higher ANP levels at baseline, whereas by 3 (P = 0.026) and 6 months (P = 0.016) these differed between groups due to divergence. There was a correlation between increasing ANP and reduced ECF at 3 months, r = -0.46, P = 0.007. in patients randomized to icodextrin, but not glucose. There were no relationships between fluid Status and any inflammatory markers at any point of the Study, with the exception of albumin at baseline, r = -0.39, P = 0.007. Amylase activities at -1 month and baseline were highly correlated, r = 0.89, P &lt; 0.0001. Within patients, concentrations of icodextrin metabolites were highly correlated: the only predictor of between-patient variability oil multivariate analysis was body weight. There was no relationship between plasma concentrations of icodextrin metabolites and any of the other clinical parameters, including change in daily Ultrafiltration, urine volume, fluid or inflammatory status. Conclusions. This analysis supports observational data that changes in fluid status are associated with changes ill urine volume. Icodextrin was not associated with a greater fall ill urine Output despite its larger effect on ECFv Changes ill fluid status Could not be explained or did not appeal to influence systemic inflammation. Nor call they be explained by individual variability in plasma concentrations of icodextrin that are in turn inversely proportional to the volume of distribution.}},
  author       = {{Davies, Simon J. and Lopez, Elvia Garcia and Woodrow, Graham and Donovan, Kieron and Plum, Jorg and Williams, Paul and Johansson, Ann Catherine and Bosselmann, Hans-Peter and Heimburger, Olof and Simonsen, Ole and Davenport, Andrew and Lindholm, Bengt and Tranaeus, Anders and Filho, Jose C. Divillo}},
  booktitle    = {{NEPHROLOGY DIALYSIS TRANSPLANTATION}},
  issn         = {{0931-0509}},
  keywords     = {{icodextrin; inflammation; fluid status; amylase; bioimpedance}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{2982--2988}},
  publisher    = {{Oxford University Press}},
  title        = {{Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange}},
  url          = {{http://dx.doi.org/10.1093/ndt/gfn176}},
  doi          = {{10.1093/ndt/gfn176}},
  volume       = {{23}},
  year         = {{2008}},
}